4.2 Article

Human microparticles generated during sepsis in patients with critical illness are neutrophil-derived and modulate the immune response

期刊

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY
卷 73, 期 2, 页码 401-406

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TA.0b013e31825a776d

关键词

Microparticles; sepsis; immune system

资金

  1. National Institutes of Health [GM08478]

向作者/读者索取更多资源

BACKGROUND: Microparticles (MPs) are 0.3 Km to 1.0 Km vesicles generated after cell activation or apoptosis that may play a role in the pathophysiology of sepsis. We sought to elucidate the role of MPs in patients with critical illness and hypothesized that MPs are generated at the site of inflammation and can modulate the immune response. METHODS: Surgical patients with critical illness with ongoing sepsis were enrolled from the intensive care unit of an urban, Level I trauma center from March to June 2011. Abdominal washings and bronchoalveolar lavage fluid were collected from sites of inflammation. MPs were isolated using differential centrifugation, then characterized by flow cytometry. Immunologic assays were conducted by incubating neutrophil-derived MPs (NDMPs) with a human monocytic cell line (THP-1). A p value <= 0.05 was considered significant. RESULTS: MPs were absent in noninflamed foci in patients, whereas NDMPs were present in locations of inflammation. NDMPs were added to cultured THP-1 cells to quantify immunomodulatory effects. THP-1 cells were able to phagocytose NDMPs. Cells that ingested NDMPs demonstrated increased activation. In contrast, bystander THP-1 cells without ingested NDMPs demonstrated decreased activation. CONCLUSION: NDMPs are generated at the site of inflammation in patients with critical illness during sepsis. They have a divergent effect on the immune response by activating phagocytic cells and deactivating bystander cells. NDMPs may play an important role in regulating the inflammatory response to sepsis in patients with critical illness. (J Trauma Acute Care Surg. 2012; 73: 401-407. Copyright (C) 2012 by Lippincott Williams & Wilkins) LEVEL OF EVIDENCE: Prognostic/epidemiologic study, level III.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据